Source: Eur Respir J 2010; 36: 972
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Hansen J.E.. Assessment of bronchoreversibility in severe emphysema. Eur Respir J 2010; 36: 972

Member's Comments

No comment yet.

Related content which might interest you: Assessment of severe COPD Source: ERS Skills course - Biomarkers and functional assessment of obstructive lung diseases Year: 2017 Assessment of severe asthma Source: ERS Skills course - Biomarkers and functional assessment of obstructive lung diseases Year: 2017 Impact of emphysema on the clinical presentation of mild to moderate COPD Source: Annual Congress 2010 - Lung imaging Year: 2010 Small-airway dysfunction among non-cystic bronchiectasis patients with different Bronchiectasis Severity Index Source: Virtual Congress 2021 – Bronchiectasis Year: 2021 Co-existent rheumatoid arthritis and non-cystic fibrosis bronchiectasis: Evidence for more severe pulmonary disease using the bronchiectasis severity index (BSI) Source: International Congress 2014 – Healthcare, prevention and adjunctive treatments in respiratory infections Year: 2014 Severity of airway obstruction in overweight/obese patients with chronic obstructive pulmonary disease(COPD) Source: International Congress 2014 – Monitoring airway diseases with lung function tests Year: 2014 Impact of moderate and severe exacerbations in severe COPD patients Source: International Congress 2018 – How far are we in terms of predicting mortality and exacerbations in COPD? Year: 2018 Assessment of non-invasive ventilation in acute severe asthma patients Source: Respiratory Failure and Mechanical Ventilation Conference 2020 Year: 2020 Predictors of severe COVID-19 in COPD Source: Virtual Congress 2021 – New evidence from longitudinal COPD cohorts and other key studies Year: 2021 Prevalence and clinical correlates of bronchoreversibility in severe emphysema Source: Eur Respir J 2010; 35: 1048-1056 Year: 2010 Morality predictors in acute exacerbation of idiopathic pulmonary fibrosis Source: International Congress 2014 – ILDs 6 Year: 2014 Episodes of Acute Respiratory Deterioration in patients with idiopathic pulmonary fibrosis in the UK – mortality and contributing factors Source: International Congress 2019 – Treatment and prognosis of idiopathic interstitial pneumonia Year: 2019 Defining severe bronchiectasis Source: Eur Respir Monogr 2018; 81: 62-81 Year: 2018 Differences in FVC decline by extent of emphysema in patients with combined pulmonary fibrosis and emphysema (CPFE) syndrome Source: International Congress 2015 – New frontiers in the management of interstitial and orphan lung diseases Year: 2015 The COPD Assessment Test in patients with non-cystic fibrosis bronchiectasisundergoing pulmonary rehabilitation Source: International Congress 2018 – Additional latest insights in pulmonary rehabilitation for chronic lung diseases Year: 2018 Assessment of disease severity using imaging scores in pulmonary sarcoidosis Source: Annual Congress 2012 - Diffuse parenchymal lung disease II Year: 2012 Performance of COPD diagnostic questionnaires in patients with moderate and severe obstruction Source: Eur Respir J 2004; 24: Suppl. 48, 473s Year: 2004 Mechanisms and consequences of exertional dyspnoea in combined pulmonary fibrosis and emphysema (CPFE) Source: International Congress 2019 – Exercise physiopathology in various respiratory diseases Year: 2019 Living well with severe asthma Source: Breathe, 15 (2) e40; 10.1183/20734735.0165-2019 Year: 2019